首页 | 本学科首页   官方微博 | 高级检索  
     


De Novo Sirolimus and Reduced‐Dose Tacrolimus Versus Standard‐Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial
Authors:S. K. Asrani  R. H. Wiesner  J. F. Trotter  G. Klintmalm  E. Katz  E. Maller  J. Roberts  N. Kneteman  L. Teperman  J. J. Fung  J. M. Millis
Affiliation:1. Division of Gastroenterology and Hepatology, Mayo Clinic, , Rochester, MN;2. William J. von Liebig Transplant Center, Mayo Clinic, , Rochester, MN;3. Annette C and Harold‐Simmons Transplant Institute, Baylor University Medical Center, , Dallas, TX;4. Transplantation, Medicines Development Group, Pfizer Specialty Care, , Collegeville, PA;5. Division of Transplant Surgery, Department of Surgery, University of California, , San Francisco, CA;6. Division of Transplantation, Department of Surgery, University of Alberta, , Edmonton, Alberta, Canada;7. New York University Medical Center, , New York, NY;8. Digestive Disease Institute, Cleveland Clinic, , Cleveland, OH;9. Section of Transplantation, Department of Surgery, University of Chicago, Transplant Center, , Chicago, IL
Abstract:
Keywords:Black box  graft failure  hepatic artery thrombosis  patient death  portal vein thrombosis  rapamycin  renal failure
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号